SCHEMBL3767699

SCHEMBL3767699

O=C(/C=C/c1c(F)cccc1Cl)N1CCN(CC(=O)N2CCN(C3CCC3)CC2)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.63
RAB9A P51151 3/20 0.55
POLB P06746 1/20 0.55
MAPT P10636 4/20 0.43
HPGD P15428 4/20 0.43
ALDH1A1 P00352 2/20 0.43
F2R P25116 1/20 0.42
KMT2A Q03164 2/20 0.42
PARP1 P09874 1/20 0.42
MDM4 O15151 1/20 0.41
MDM2 Q00987 1/20 0.41
NPC1 O15118 2/20 0.41
HRH3 Q9Y5N1 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
ALOX12 P18054 1/20 0.39
ATM Q13315 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3767708 1.00 TDP1 (0.63) TDP1RAB9APOLBMAPTHPGD
SCHEMBL3769147 0.93 TDP1 (0.52) TDP1RAB9APOLBMAPTHPGD
SCHEMBL3769143 0.93 TDP1 (0.52) TDP1RAB9APOLBMAPTHPGD
SCHEMBL3767573 0.84 PARP1 (0.43) TDP1MAPTALDH1A1F2RKMT2A
SCHEMBL3767564 0.84 PARP1 (0.43) TDP1MAPTALDH1A1F2RKMT2A
SCHEMBL3803381 0.84 C3AR1 (0.47) TDP1MAPTALDH1A1F2RKMT2A
SCHEMBL3803380 0.84 C3AR1 (0.47) TDP1MAPTALDH1A1F2RKMT2A
SCHEMBL3769364 0.84 L3MBTL1 (0.60) TDP1POLBMAPTALDH1A1F2R
SCHEMBL3769370 0.84 L3MBTL1 (0.60) TDP1POLBMAPTALDH1A1F2R
SCHEMBL3774011 0.83 KMT2A (0.63) TDP1RAB9AMAPTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
WO-2007016496-A2 DIPIPERAZINYL KETONES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2007-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049571-A1 Dipiperazinyl ketones and related analogues HRH4, HRH3, HRH1 TDP1 4483/4885RAB9A 3824/4885POLB 4363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.